Global Medical Technology Industry Dynamics, Insights, and Announcements
Oncuria is the first-of-its-kind multiplex urine test for the quantitative detection of 10 biomarkers in urine that are associated with the presence of bladder cancer
Read More
AnchorDx obtained a European Access Permit for in-vitro diagnostics devices (IVDD) authorized by the Netherlands CIBG of Ministry of Health, Welfare and Sport
Read More
Sysmex America’s XN-10™ with Blood Bank Mode is First and Only Automated Hematology Analyzer to be FDA-Cleared for residual WBC counting
Read More
New offering from Thermo Fisher Scientific expands instrument capabilities beyond allergy diagnostics
Read More
Urgent solutions for the certification of new, innovative tests greatly needed and expected by patients
Read More
New multiplex panel can detect SARS-CoV-2, Flu A, Flu B & RSV at the Point of Need; Accurate PCR results delivered in approximately 30 minutes
Read More
Latest addition to Company’s genomic testing services menu delivers rapid results to physicians that inform clinical management and outcomes for critically ill patients
Read More
510(k) Clearance of BD COR™ MX Instrument Elevates Standard of Care for Sexually Transmitted Infections
Read More
the first FDA-authorized in vitro diagnostic test in the U.S. to aid in the assessment of Alzheimer’s disease and other causes of cognitive decline
Read More
to combine Zymo Research’s nucleic acid purification and assay technologies with Star Array’s engineering and automation expertise to expand into POCT market
Read More